Article Type
Changed
Thu, 12/15/2022 - 17:44

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Meeting/Event
Publications
Topics
Sections
Meeting/Event
Meeting/Event

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

In this special edition of the MDedge Daily News, Nick Andrews and Terry Rudd report the latest news from the 2018 San Antonio Breast Cancer Symposium. Stories include: uUing low-dose tamoxifen, the latest findings from the KATHERINE trial, results of a meta-analysis of neoadjuvant chemotherapy, and capecitabine in early stage triple negative breast cancer.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

 

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica